Postmenopausal women on transdermal HT experienced lower incidence of anxiety and depression compared with those receiving oral HT
Burden greater for psychological and somatic menopause symptoms, but not vasomotor symptoms
Authors say more studies are needed to understand ideal timing window for treatment initiation
Initiating systemic hormone therapy before age 50 years linked to increased risk for depression